Forbes 30 Under 30 · Healthcare
Biotech Entrepreneur. Author. Advisor.
Bridging cutting-edge science and market impact.
Stephanie A. Wisner is a biotech entrepreneur, investor, and educator on a mission to accelerate life-changing science from lab to market. She is co-founder and Chief Business Officer of Centivax, a biotech startup, and founder of BioVenture Advising LLC, where she consults with biotech companies on business and commercialization strategy.
Previously, Stephanie worked at ARCH Venture Partners, one of the world's premier deep-tech venture firms. She brings together deep scientific expertise — rooted in chemistry and cancer research — with the financial and entrepreneurial acumen of her Chicago Booth MBA.
She serves as Entrepreneur-in-Residence and Visiting Faculty at Cornell University Johnson School of Business, where her book is taught alongside other top institutions including Dartmouth, Johns Hopkins, and Penn State.
Healthcare · 2022
Entrepreneur-in-Residence & Visiting Faculty, Johnson School of Business
MBA · Finance, Accounting & Entrepreneurship
BS · Chemistry & Chemical Biology
Independent cancer research
The Power of Entrepreneurship to Drive Cutting-Edge Science to Market
What does it take to transform a scientific breakthrough into a company that changes lives? Building Backwards to Biotech is the definitive guide for scientists and entrepreneurs navigating the complex path from research to commercialization.
With real-world frameworks drawn from Stephanie's experience co-founding a biotech startup, advising venture-backed companies, and working at the frontier of deep-tech investing, this book gives readers the strategic tools to move science forward — and to market.
Stephanie brings her unique blend of scientific expertise and entrepreneurial experience to lecture series, conferences, and classroom settings at top universities and research institutions.
Interested in having Stephanie speak at your institution or event?
Inquire About SpeakingPeer-reviewed science, industry analysis, and thought leadership spanning biotechnology, synthetic biology, and healthcare innovation.
Whether you're a biotech founder seeking strategic guidance, an institution interested in booking a speaker, or a fellow scientist ready to bring your work to market — Stephanie would love to hear from you.